Andrew Morozov
Investitore di Private Equity presso CISCO SYSTEMS, INC.
Profilo
Andrew Morozov is currently an Independent Director at CureLab Oncology, Inc., a Corporate Business Development & Investment Manager at Cisco Systems, Inc., and a Partner at Gauss Ventures Ltd.
He previously worked as a Principal at TL Ventures, Inc. from 2000 to 2004.
Dr. Morozov holds an MBA degree from The Wharton School of the University of Pennsylvania.
Posizioni attive di Andrew Morozov
| Società | Posizione | Inizio |
|---|---|---|
| CISCO SYSTEMS, INC. | Investitore di Private Equity | - |
CureLab Oncology, Inc.
 CureLab Oncology, Inc. BiotechnologyHealth Technology Part of Curelab Veterinary, Inc., CureLab Oncology, Inc. is a pre-IPO, clinical-stage biotech company headquartered in the greater area. The company is based in Boston, MA. The company is dedicated to advancing new and safer therapeutics for solid tumors and other oncology and inflammatory indications. CureLab Oncology is developing an experimental DNA therapy called p62/sqstm1, which consists of a circular piece of DNA called a plasmid that includes a gene for a human protein. The company was founded by Alexander Shneider, who has been the CEO since incorporation. | Direttore/Membro del Consiglio | - |
Gauss Ventures Ltd.
 Gauss Ventures Ltd. Investment ManagersFinance Gauss Ventures Ltd. (Gauss Ventures) is a venture capital firm, founded in 2017. It is headquartered in London. | Investitore di Private Equity | 01/02/2018 |
Precedenti posizioni note di Andrew Morozov
| Società | Posizione | Fine |
|---|---|---|
TL Ventures, Inc.
 TL Ventures, Inc. Investment ManagersFinance TL Ventures Inc (TL Ventures) is a venture capital subsidiary of Safeguard Scientifics, Inc. founded in 1988 by Robert Keith. The firm is headquartered in Wayne, Pennsylvania. | Investitore di Private Equity | 01/01/2004 |
Formazione di Andrew Morozov
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CISCO SYSTEMS, INC. | Technology Services |
| Aziende private | 3 |
|---|---|
TL Ventures, Inc.
TL Ventures, Inc. Investment ManagersFinance TL Ventures Inc (TL Ventures) is a venture capital subsidiary of Safeguard Scientifics, Inc. founded in 1988 by Robert Keith. The firm is headquartered in Wayne, Pennsylvania. | Finance |
Gauss Ventures Ltd.
Gauss Ventures Ltd. Investment ManagersFinance Gauss Ventures Ltd. (Gauss Ventures) is a venture capital firm, founded in 2017. It is headquartered in London. | Finance |
CureLab Oncology, Inc.
CureLab Oncology, Inc. BiotechnologyHealth Technology Part of Curelab Veterinary, Inc., CureLab Oncology, Inc. is a pre-IPO, clinical-stage biotech company headquartered in the greater area. The company is based in Boston, MA. The company is dedicated to advancing new and safer therapeutics for solid tumors and other oncology and inflammatory indications. CureLab Oncology is developing an experimental DNA therapy called p62/sqstm1, which consists of a circular piece of DNA called a plasmid that includes a gene for a human protein. The company was founded by Alexander Shneider, who has been the CEO since incorporation. | Health Technology |
- Borsa valori
- Insiders
- Andrew Morozov
